Pflug Koory’s Edwards Lifesciences EW Stock Holding History

Pflug Koory’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.86K	Hold	109	–	–	﹤0.01%	342
2026 Q1	$8.73K	Hold	109	–	–	﹤0.01%	340
2025 Q4	$9.29K	Hold	109	–	–	﹤0.01%	337
2025 Q3	$8.48K	Hold	109	–	–	﹤0.01%	336
2025 Q2	$8.53K	Hold	109	–	–	﹤0.01%	332
2025 Q1	$7.9K	Hold	109	–	–	﹤0.01%	322
2024 Q4	$8.07K	Hold	109	–	–	﹤0.01%	330
2024 Q3	$7.19K	Buy	+109	New	+$7.92K	﹤0.01%	331
2024 Q1	$10.4K	Hold	109	–	–	0.01%	321
2023 Q4	$8.31K	Hold	109	–	–	﹤0.01%	331
2023 Q3	$7.55K	Hold	109	–	–	﹤0.01%	332
2023 Q2	$10.3K	Hold	109	–	–	0.01%	322
2023 Q1	$9.02K	Hold	109	–	–	﹤0.01%	334
2022 Q4	$8K	Hold	109	–	–	﹤0.01%	346
2022 Q3	$9K	Buy	+109	New	+$10.5K	0.01%	351

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Pflug Koory's EW Position: Q2 2026 in Review

Pflug Koory held its Edwards Lifesciences (EW) position steady in Q2 2026 at 109 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

Pflug Koory first reported a position in EW in Q3 2022 and has held it in 15 quarters since. The position peaked at $10.4K in Q1 2024. 265 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Pflug Koory held 109 shares of Edwards Lifesciences worth $9.86K as of Q2 2026.
Pflug Koory left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of Pflug Koory's portfolio in Q2 2026, its #342 holding.
Pflug Koory first reported a position in Edwards Lifesciences in Q3 2022 and has held it in 15 quarters since.
Pflug Koory's Edwards Lifesciences position peaked at $10.4K in Q1 2024.
265 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.